SecBot SecBot
S-3 ·Filed Oct 26, 2026

ABOS

Acumen Pharmaceuticals, Inc.
BEARISH
Impact 5/10
Processed20h 47m ago SEC0001628280-26-067291
Shelf registration — potential dilution

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001628280-26-067291
Exhibit: exhibit45-sx3oct2026.htm0001628280-26-067291
Exhibit: exhibit44-sx3oct2026.htm0001628280-26-067291
Exhibit: exhibit46-sx3oct2026.htm0001628280-26-067291
17 reports for ABOS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ABOS — sortable, filterable
TypeNow
Oct 26, 2026
today
S-3
BEARISH ★ 5/10
$2.27awaiting T+20—$2.19 (+3.31%)
Oct 26, 2026
1d ago
8-K
NEUTRAL ★ 6/10
$2.07awaiting T+20—$2.19 (+6.09%)
Oct 26, 2026
1d ago
Press Release
NEUTRAL ★ 5/10
$2.05awaiting T+20—$2.19 (+7.07%)
Oct 22, 2026
5d ago
Press Release
NEUTRAL ★ 3/10
$2.06awaiting T+20—$2.19 (+6.55%)
Oct 19, 2026
7d ago
Press Release
NEUTRAL ★ 1/10
$2.02awaiting T+20—$2.19 (+8.93%)
Sep 16, 2026
5w ago
8-K
NEUTRAL ★ 3/10
$2.61 $1.82▼ −30.46%▼ −33.64%$2.19 (−15.90%)
Aug 12, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$2.51 $2.86▲ +13.94%▲ +15.84%$2.19 (−12.55%)
Aug 12, 2026
10w ago
8-K
NEUTRAL ★ 5/10
$2.51 $2.86▲ +13.94%▲ +15.84%$2.19 (−12.55%)
Aug 12, 2026
10w ago
Press Release
BEARISH ★ 5/10
$2.51 $2.86▼ −13.94%▼ −15.84%$2.19 (+12.55%)
Jun 17, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$2.26 $2.17▼ −3.98%▼ −4.52%$2.19 (−2.88%)
Showing 10 of 17

US Market Status

Market Open — Closes in 2h 50m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh ABOS Intelligence

Analysis is for subscribers only.

Subscribe for Full Access